ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

NCI funds 17 EDRN biomarker labs. Bush signs omnibus funding legislation.

December 10, 2004

Virus Cancer Program Includes “Some Of The Bes Basic Research Anywhere,” Moloney Says

January 9, 1976